MEDIA ROOM

Welcome to the Swiss Nordic Bio media room . Here you can find press releases and news related to Swiss Nordic Bio.

Interview with Matthias Steger, Global Head of Research and Technology Partnering at F Hoffmann-La Roche

Interview with the CEO and Founder of Venture Valuation, Patrik Frei

International Innovation is the leading global dissemination resource for the wider scientific, technology and research communities, dedicated to disseminating the latest science, research and technological innovations on a global level. More information and a complimentary subscription offer to the publication can be found here.

MAIN SPONSOR

REGISTRATION

IMPORTANT DEADLINES

31 Jan 2021
End of registration

1 Jan - 31 Jan
Booking of 1-to-1 meetings

10 & 11 Feb 2021
Event date

Life Science Sweden

LifeSciSwe

Patrik Dahlen, ny vd på @immunovia, ser framemot att börja jobba med bolagets tidiga diagnostik av cancer.
Plusartikel – vi bjuder dig som följer oss i sociala medier.
https://t.co/WLxmz6xE8u 1 Retweets

SWISS NORDIC BIO Retweeted

Forskningsparken - Oslo Science Park

OsloSciencePark

Hver måned velter 20.000 tørre blodprøver inn fra 50 land til Vitas i Forskningsparken i Oslo. 24 timer senere vet amerikanere, asiater og australiere om de behøver vaksine.
https://t.co/zwSS7PmrnY
@OsloScienceCity @LifeScienceNO @ShareLabOslo 4 Retweets

SWISS NORDIC BIO Retweeted

Boehringer Ingelheim

Boehringer

Scientists around the world are committed to developing multiple approaches to fight #COVID19. Our #TRPC6 inhibitor could potentially help closing the gap in the therapeutic options that are being researched 27 Retweets

SWISS NORDIC BIO Retweeted

PREVIOUS PARTICIPANTS

Apus Capital

ArchiMed

BB Biotech

Credit Suisse

Eiffel Investment Group

Veraison Capital AG

Johnson and Johnson Innovation

Novartis Venture Fund

Occident Group

Redalpine Venture Partners

F.Hoffmann-La Roche Ltd

Capital Rewards Partners

Creathor Venture

Management GmbH

Endeavour Vision SA

Merck Ventures BV

Novo A/S (Ventures)

Debiopharm International SA

Lipum AB

Bay City Capital

HBM Partners Ltd.

Industrifonden

MTIP MedTech Innovation Partners AG

PM Equity Partner

Signature Seven Partners

Wille Finance AG

XOventure GmbH

Sunstone Capital

Dottikon Exclusive Synthesis AG